OLEMA PHARMACEUTICALS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-3.1M | $-3.1M | — | — |
| FY2020 | $-19.9M | $-19.9M | $56.0K | $3.1M |
| FY2021 | $-50.7M | $-52.3M | $1.6M | $15.9M |
| FY2022 | $-82.1M | $-82.4M | $363.0K | $18.8M |
| FY2023 | $-83.7M | $-83.7M | — | $17.3M |
| FY2024 | $-104.4M | $-104.5M | $159.0K | $22.6M |
| FY2025 | $-146.7M | $-146.7M | — | $17.6M |